ADVFN ADVFN

Wir konnten keine Ergebnisse für:
Stelle sicher, dass deine Schreibweise korrekt ist oder versuche deine Suche zu erweitern.

Trends

Toplisten

Es scheint, dass du nicht eingeloggt bist.
Klicke auf den Button unten, um dich einzuloggen und deine zuletzt angesehenen Aktien zu sehen.

Hot Features

Icon for alerts Registrieren Sie sich für Echtzeit-Benachrichtigungen, benutzerdefinierte Portfolios und Marktbewegungen.
Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics Inc (GLUE)

24,21
0,19
(0,79%)
Geschlossen 03 Juli 10:00PM
24,21
0,00
( 0,00% )
Vor Marktöffnung: 12:09PM

Monte Rosa Therapeutics Inc (GLUE) Eigentumsverteilung

Institutionen
75.06%
Insider
0.55%
Öffentlichkeit und Andere
24.39%

Monte Rosa Therapeutics Inc (GLUE) Eigentum

Aktionär Typ Gehalten (Tatsächlich) % Ausstehender Aktien Marktwert Positionsdatum
New Enterprise Associates, Inc.Institution7.692.2989,11%US$ 186,23M2026-03-31
New Enterprise Associates 17, L.P.Institution7.692.2989,11%US$ 186,23M2026-03-17
T. Rowe Price Group, Inc.Institution6.720.1887,95%US$ 162,70M2026-03-31
BlackRock, Inc.Institution5.637.6846,67%US$ 136,49M2026-03-31
TCG Crossover Management, LLCInstitution4.622.1515,47%US$ 111,90M2026-03-31
BVF Partners L.P.Institution4.460.8865,28%US$ 108,00M2026-03-31
Baker Bros. Advisors LPInstitution4.345.7365,14%US$ 105,21M2026-03-31
Suvretta Capital Management, LLCInstitution4.226.8095,00%US$ 102,33M2026-03-31
Vestal Point Capital, LPInstitution3.603.4654,27%US$ 87,24M2026-03-31
State Street Global Advisors, Inc.Institution3.353.9803,97%US$ 81,20M2026-03-31
Braidwell LPInstitution3.206.5743,80%US$ 77,63M2026-03-31
Versant Venture Management, LLCInstitution3.180.7803,77%US$ 77,01M2026-03-31
Averill Master Fund, Ltd.Institution3.147.4483,73%US$ 76,20M2025-04-09
Vanguard Capital Management, LLCInstitution3.100.2453,67%US$ 75,06M2026-03-31
American Century Investment Management IncInstitution2.809.6473,33%US$ 68,02M2026-03-31
Biotechnology Value Fund L.P.Institution2.382.7322,82%US$ 57,69M2026-03-31
Versant Venture Capital VIInstitution2.236.7082,65%US$ 54,15M2026-01-08
TCG Crossover Fund II, L.P.Institution2.213.8532,62%US$ 53,60M2025-10-10
Silverarc Capital Management, LLCInstitution2.002.0402,37%US$ 48,47M2026-03-31
Biotechnology Value Fund II, L.P.Institution1.742.8062,06%US$ 42,19M2026-03-31
Aisling Capital Management LPInstitution1.555.6641,84%US$ 37,66M2026-03-31
Geode Capital Management, LLCInstitution1.540.8121,82%US$ 37,30M2026-03-31
Marshall Wace LLPInstitution1.433.1521,70%US$ 34,70M2026-03-31
Bellevue Asset Management AGInstitution1.250.0001,48%US$ 30,26M2026-03-31
MPM BioImpact LLCInstitution1.176.9281,39%US$ 28,49M2026-03-31
Dimensional Fund Advisors LPInstitution1.041.3721,23%US$ 25,21M2026-03-31
FMR LLCInstitution1.024.3041,21%US$ 24,80M2026-03-31
Versant Vantage I, L.P.Institution1.013.3611,20%US$ 24,53M2026-01-08
Frazier Life Sciences Management, LPInstitution1.000.0001,18%US$ 24,21M2026-03-31
The Goldman Sachs Group, Inc.Institution891.1581,05%US$ 21,57M2026-03-31
Bridgeway Capital Management, LLCInstitution834.0960,99%US$ 20,19M2026-03-31
Northern Trust Global InvestmentsInstitution826.6240,98%US$ 20,01M2026-03-31
Janus Henderson Group plcInstitution685.9260,81%US$ 16,61M2026-03-31
GV Management Company, LLCInstitution684.2750,81%US$ 16,57M2026-03-31
Nantahala Capital Management, LLCInstitution651.9930,77%US$ 15,78M2026-03-31
Arrowstreet Capital, Limited PartnershipInstitution647.7390,77%US$ 15,68M2026-03-31
First Trust Advisors LPInstitution647.4460,77%US$ 15,67M2026-06-30
AQR Capital Management, LLCInstitution621.6970,74%US$ 15,05M2026-03-31
Morgan StanleyInstitution582.9690,69%US$ 14,11M2026-03-31